U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
7371173711Study of Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Patients With Medulloblastomas With an Activation of the Sonic Hedgehog PathwayRecruitingNo Results AvailableHistologically Confirmed Medulloblastoma|Activation of the Sonic Hedgehog (SHH) PathwayDrug: vismodegib|Drug: Temozolomidehttps://ClinicalTrials.gov/show/NCT01601184
7371273712The Genetic Investigation of Reproductive Disorders (Including Kallmann Syndrome)RecruitingNo Results AvailableKallmann Syndrome|Hypogonadotropic Hypogonadism|Hypothalamic Amenorrhea|Polycystic Ovarian Syndrome|Precocious Pubertyhttps://ClinicalTrials.gov/show/NCT01601171
7371373713Umbilical Cord Blood Therapy for Children With Global Developmental DelayCompletedNo Results AvailableGlobal Developmental DelayBiological: Umbilical Cord Blood administration|Other: Active Rehabilitationhttps://ClinicalTrials.gov/show/NCT01601158
7371473714Effect of Probiotic on the Plaque pH. A Randomized Double Blind Interventional StudyCompletedNo Results AvailablePlaque Ph Lowering After Use of Probiotics|Caries|GingivitisDietary Supplement: consumption of lozengeshttps://ClinicalTrials.gov/show/NCT01601145
7371573715Drug Interaction Study of Colchicine and TheophyllineCompletedHas ResultsHealthyDrug: theophylline|Drug: colchicinehttps://ClinicalTrials.gov/show/NCT01601132
7371673716Impact of Disease Modifying Therapies (DMTs) and Associated Support Services in Relapsing Multiple Sclerosis (RMS) PatientsCompletedNo Results AvailableRelapsing Multiple SclerosisDrug: Rebif|Other: Other: Disease modifying therapies (DMT)https://ClinicalTrials.gov/show/NCT01601119
7371773717Silencing Inflammatory Activity by Injecting Nanocort in Patients at Risk for Atherosclerotic DiseaseRecruitingNo Results AvailableAtherosclerosis|InflammationDrug: liposomal prednisolone|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01601106
7371873718Study on Ceftazidime and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract InfectionRecruitingNo Results AvailableRespiratory Tract Infections|Urinary Tract InfectionsDrug: High dose|Drug: Low dose|Drug: Cefoperazone and Sulbactam Sodium (CFP/SUB)https://ClinicalTrials.gov/show/NCT01601093
7371973719An Observational, Retrospective, UK & Ireland Audit of Patient Adherence to Rebif® Injections Using the RebiSmart™ Injection DeviceCompletedNo Results AvailableRelapsing Multiple Sclerosishttps://ClinicalTrials.gov/show/NCT01601080
7372073720Integrated Alcohol Disorder and PTSD TreatmentRecruitingNo Results AvailablePTSD|AlcoholismBehavioral: Integrated Prolonged Exposure Therapy|Behavioral: Seeking Safetyhttps://ClinicalTrials.gov/show/NCT01601067
7372173721Supplemental Anterior Lumbar Interbody Fusion (ALIF) in Spinal DeformityRecruitingNo Results AvailableSpinal DeformityDevice: Tantalum cage from Zimmerhttps://ClinicalTrials.gov/show/NCT01601054
7372273722Role of Residual Urine and Asymptomatic Prostatitis in the Development of Urinary Tract Infections in Spinal Cord InjuryCompletedNo Results AvailableUrinary Tract InfectionOther: sonographic assessment of residual urine, urine culturehttps://ClinicalTrials.gov/show/NCT01601041
7372373723Hydroxychloroquine Treatment of Dry Eyes in Patients With Primary Sjögren's SyndromeCompletedNo Results AvailableAutoimmune Diseases|Sjogren's Syndrome|Dry EyeDrug: Hydroxychloroquine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01601028
7372473724Effectiveness of the Treatment of Tension-type Headache With Manual and Manipulative TherapyCompletedNo Results AvailableTension-type HeadacheOther: Manual Therapy|Other: Manual Therapy|Other: Manual Therapy|Other: placebo treatmenthttps://ClinicalTrials.gov/show/NCT01601015
7372573725LEPR Polymorphism Weight Gain by Mirtazapine in Late Life DepressionRecruitingNo Results AvailableMajor Depressive DisorderDrug: Mirtazapinehttps://ClinicalTrials.gov/show/NCT01601002
7372673726Mitochondrial Function of Immune Cells in SepsisCompletedNo Results AvailableShock, SepticOther: blood sampling|Other: blood samplinghttps://ClinicalTrials.gov/show/NCT01600989
7372773727A Study to Assess Safety and Pharmacokinetics of Telaprevir in Patients With Hepatic ImpairmentCompletedNo Results AvailableHepatic ImpairmentDrug: telaprevirhttps://ClinicalTrials.gov/show/NCT01600976
7372873728A Study to Evaluate the Efficacy and Safety of TMC207 in Patients With Pulmonary Infection With Multi-drug Resistant Mycobacterium TuberculosisWithdrawnNo Results AvailableMulti-drug Resistant TuberculosisDrug: Arm A Double-blind Phase: TMC207|Drug: Arm B Double-blind Phase: Placebo|Drug: Treatment Failure During Double-blind Phase: TMC207|Drug: Treatment Failure During Follow-up Phase: TMC207https://ClinicalTrials.gov/show/NCT01600963
7372973729A Study to Compare LY2963016 to Lantus After a Single Dose to Participants With Type 1 Diabetes MellitusCompletedHas ResultsDiabetes Mellitus, Type 1Drug: LY2963016|Drug: Lantushttps://ClinicalTrials.gov/show/NCT01600950
7373073730Italian Diabetes and Exercise Study 2Active, not recruitingNo Results AvailableType 2 DiabetesBehavioral: Theoretical & practical exercise counselinghttps://ClinicalTrials.gov/show/NCT01600937
7373173731Study on the Assessment of Determinants of Muscle and Bone Strength Abnormalities in DiabetesActive, not recruitingNo Results AvailableType 1 Diabetes|Type 2 Diabeteshttps://ClinicalTrials.gov/show/NCT01600924
7373273732Establish a Vegetable Signature Database From Human Metabolomics ResponsesActive, not recruitingNo Results AvailableHuman Metabolomic Responses to Plant Foods|Blood PressureOther: Low phytochemical diet(LPD), high phytochemical diet(HPD)https://ClinicalTrials.gov/show/NCT01600911
7373373733Screening of Pulmonary Arterial Hypertension in BMPR2 Mutation CarriersActive, not recruitingNo Results AvailablePulmonary Arterial Hypertensionhttps://ClinicalTrials.gov/show/NCT01600898
7373473734The Effects of Ketamine and Guanfacine on Working Memory in Healthy SubjectsCompletedHas ResultsNMDA Receptor FunctionDrug: Guanfacine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01600885
7373573735Oxidative Stress and Bisphenol A (BPA) Impact With Polycystic Ovary Syndrome (PCOS)RecruitingNo Results AvailableOxidative Stress|Endocrine Disrupting Chemicals|Polycystic Ovary Syndromehttps://ClinicalTrials.gov/show/NCT01600872
7373673736Evaluation of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (Study: E2609-A001-101 Amendment 02)CompletedNo Results AvailableAlzheimer's DiseaseDrug: E2609|Drug: Placebo for E2609https://ClinicalTrials.gov/show/NCT01600859
7373773737Pharmacogenetic Testing in Primary CareCompletedNo Results AvailablePharmacogenetic Testinghttps://ClinicalTrials.gov/show/NCT01600846
7373873738The Association of Ferrtin and Homocysteine Etc. With RI and MS in Polycystic Ovary Syndrome (PCOS)CompletedNo Results AvailablePolycystic Ovary Syndromehttps://ClinicalTrials.gov/show/NCT01600833
7373973739Effect of the Consumption of a Fermented Milk Enriched With Plant Sterols (Spain)CompletedNo Results AvailableHypercholesterolemiaOther: 1- Low fat drinkable fermented dairy product enriched with 1.6g of plant sterol (as free equivalent) per unit|Other: 2- Low fat drinkable fermented dairy product enriched with 2.0g of plant sterol (as free equivalent) per unit|Other: 3- Low fat drinkable fermented dairy product without plant sterols(control)https://ClinicalTrials.gov/show/NCT01600820
7374073740OSI-906 With Gemcitabine and Erlotinib for Metastatic Ductal Adenocarcinoma of the PancreasWithdrawnNo Results AvailablePancreatic Cancer, MetastaticDrug: Gemcitabine, Erlotinib, OSI-906|Drug: Gemcitabine, Erlotinibhttps://ClinicalTrials.gov/show/NCT01600807

* Görseller ve İçerik tekif hakkına sahip olabilir